News Briefs: July 13, 2020

Ophthalmic Consultants PA in Sarasota, Florida, agreed to pay $4.8 million to settle false claims allegations that it billed Medicare and other federal payers for multi-dosing patients from single-use vials of ranibizumab and Eylea, the U.S. Attorney’s Office for the Middle District of Florida said June 30.[1] The practice didn’t admit liability in the settlement.

This document is only available to subscribers. Please log in or purchase access.
 


Would you like to read this entire article?

If you already subscribe to this publication, just log in. If not, let us send you an email with a link that will allow you to read the entire article for free. Just complete the following form.

* required field